FLT3 inhibitors – an ideal strategy for treating FLT3-mutated AML
Treatment for older AML patients - when is an allogeneic transplant suitable?
Predict response to immune checkpoint inhibition in acute myeloid leukemia (AML) using biomarkers
Naval G. Daver
Good nursing care is the key to veno-occlusive disease (VOD) management
Exploring combinatorial approaches in acute myeloid leukemia (AML) treatment
Francesco Lo Coco